Fortrea Holdings Inc. (FTRE)

23.97 -0.73 (-2.96%) 收市：04:00PM EDT

Fortrea Holdings Inc.

8 Moore Drive
Durham, NC 27709
United States
877 495 0816
https://www.fortrea.com

版塊: Healthcare
行業: Biotechnology
全職員工: 16,000

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Thomas H. Pike	CEO, President & Chairman	2.19M	無	1959
Ms. Jill McConnell	Chief Financial Officer	735.39k	無	1975
Mr. Mark A. Morais	COO & President of Clinical Services	732.47k	無	1977
Amanda M. Warren	Chief Accounting Officer	無	無	無
Ms. Hima B. Inguva	Head of Investor Relations & Corporate Development	無	無	無
Stillman Hanson	General Counsel & Corporate Secretary	無	無	無
Dr. John J. Doyle	President of Consulting	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

公司管治

截至 2024年6月1日 止，Fortrea Holdings Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：8；董事會：7；股東權利：5；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。